BAXTER Compound Sodium Lactate Solution and 5% Glucose 1000mL injection AHB2074 Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate solution and 5% glucose 1000ml injection ahb2074

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

BAXTER Compound Sodium Lactate Solution and 5% Glucose 500mL injection AHB2073 Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

baxter compound sodium lactate solution and 5% glucose 500ml injection ahb2073

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

Compound Sodium Lactate Intravenous Infusion BP, Solution for Infusion (Hartmann’s Solution) Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

compound sodium lactate intravenous infusion bp, solution for infusion (hartmann’s solution)

b. braun medical limited - sodium chloride; potassium chloride; sodium lactate solution; calcium chloride dihydrate - solution for infusion - 6/6.24/0.40/0.27 %v/v - solutions affecting the electrolyte balance; electrolytes

COMPOUND SODIUM LACTATE & GLUCOSE 5% %v/v Solution for Infusion Իռլանդիա - անգլերեն - HPRA (Health Products Regulatory Authority)

compound sodium lactate & glucose 5% %v/v solution for infusion

baxter healthcare limited - sodium chloride potassium chloride calcium chloride dihydrate sodium lactate glucose monohydrate - solution for infusion - %v/v

Compound Sodium Lactate (Hartmanns) Նոր Զելանդիա - անգլերեն - Medsafe (Medicines Safety Authority)

compound sodium lactate (hartmanns)

baxter healthcare ltd - calcium chloride dihydrate 0.2684 mg/ml; potassium chloride 0.4 mg/ml; sodium chloride 6 mg/ml; sodium lactate 3.33 mg/ml (formed in process from lactic acid + sodium hydroxide) - solution for infusion - active: calcium chloride dihydrate 0.2684 mg/ml potassium chloride 0.4 mg/ml sodium chloride 6 mg/ml sodium lactate 3.33 mg/ml (formed in process from lactic acid + sodium hydroxide) excipient: water for injection - compound sodium lactate (hartmanns) infusion solution is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. this solution is indicated as a method of intravenous drug delivery, if the drugs are compatible with the solution

BAXTER 0.22% POTASSIUM CHLORIDE and HARTMANN'S SOLUTION injection AHB2954 Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

baxter 0.22% potassium chloride and hartmann's solution injection ahb2954

baxter healthcare pty ltd - sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 2.2 g/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: lactic acid; sodium hydroxide; water for injections - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

Plasma-Lyte 148 (ph 7.4) Solution for Infusion N/A Մալթա - անգլերեն - Medicines Authority

plasma-lyte 148 (ph 7.4) solution for infusion n/a

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions

Plasma-Lyte 148 (ph 7.4) Solution for Infusion N/A Մալթա - անգլերեն - Medicines Authority

plasma-lyte 148 (ph 7.4) solution for infusion n/a

baxter healthcare limited - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium gluconate - solution for infusion - sodium chloride 5.26 g/l; potassium chloride 0.37 g/l; magnesium chloride hexahydrate 0.30 g/l; sodium acetate trihydrate 3.68 g/l; sodium gluconate 5.02 g/l - blood substitutes and perfusion solutions